US Patent Issued to Gilead Sciences on April 7 for "Therapeutic compositions for treatment of human immunodeficiency virus" (California Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,244, issued on April 7, was assigned to Gilead Sciences Inc. (Foster City, Calif.).

"Therapeutic compositions for treatment of human immunodeficiency virus" was invented by Benjamin Micah Collman (San Mateo, Calif.), Lei Hong (Cupertino, Calif.) and Joanna M. Koziara (Foster City, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A solid oral dosage form is provided, comprising a compound of Formula I or a pharmaceutically acceptable salt thereof, tenofovir alafenamide or a pharmaceutically acceptable salt thereof, and emtricitabine or a pharmaceutically acceptable salt thereof."

The patent was filed on Sept. 29, 2025, under Application No. 19/...